Upcoming Meetings: Plasma product meeting
This article was originally published in The Gray Sheet
Executive Summary
Plasma product meeting: FDA, National Heart Lung and Blood Institute and the Center for Disease Control and Prevention sponsoring a Nov. 19 meeting to discuss public notification of withdrawals and recalls of plasma-derived products. Information will be exchanged on "available notification resources"; "the roles and responsibilities of public health service agencies, manufacturers, distributors, and private organizations in the notification process"; and "improving the notification system." The meeting is being held at the National Instites of Health in Bethesda, Maryland. For further information, contact Joseph Wilczek in FDA's Office of Blood Research and Review at 301/827-3512...